Investment Advisor Bets CMPX Stock: Big Stake Signals Conviction
A prominent investment advisor added a sizable CMPX position, signaling strong conviction in Compass Therapeutics. He...
Identify compelling low-cost index funds for retirement by evaluating tracking error, fees, and diversification. Build a lineup aligned with long-term goals.
27,243 articlesA prominent investment advisor added a sizable CMPX position, signaling strong conviction in Compass Therapeutics. He...
Circle has delivered a dramatic swing in 2024. This article breaks down the main reason it could keep climbing, the r...
Canopy Growth is restating two years of earnings ahead of June earnings. This article breaks down what it means, how ...
Bitcoin faces a looming quantum threat as experts warn Q-Day could arrive around 2030. Galaxy Digital's up-to-$5 mill...
GTS Securities recently sold a large chunk of its XOVR exposure, shedding about 19.46 million shares worth roughly 35...
This article breaks down Quaker Chemical's Q4 2025 earnings implications, real-world drivers, and practical steps you...
A sharp, near-$99 million exit from this cybersecurity stock has analysts buzzing about a possible shift in investor ...
Solana has faced a meaningful pullback in the past three months. This guide breaks down whether solana still worth bu...
Oracle slipped this year, but does that mean it's a no-brainer AI buy? This practical guide weighs AI potential, fina...
BITO’s 0.95% fee is only part of the cost. When roll losses from contango are added, total annual drag nears 3% for b...
When Hamilton Beach reports earnings, investors gain clues about demand for small appliances and margin discipline. T...
Nvidia has stumbled from its record highs in 2026, but a dip can offer opportunity—if you know how to evaluate the od...